title: Neutralization epitopes on HIV pseudotyped with HTLV-I: conservation of carbohydrate epitopes.
abstract: One mechanism for expanding the cellular tropism of human immunodeficiency virus (HIV) in vitro is through formation of phenotypically mixed particles (pseudotypes) with human T lymphotropic virus type I (HTLV-I). In this study we found that pseudotypes allow penetration of HIV particles into CD4-negative cells, previously nonsusceptible to HIV infection. The infection of CD4-negative cells with pseudotypes could be blocked with anti-HTLV-I serum but failed to be significantly inhibited with anti-HIV serum or a V3-neutralizing anti-gp120 monoclonal antibody. This may represent a possibility for pseudotypes to escape neutralization by the immune system in vivo. Previous reports have suggested that carbohydrate structures may be conserved neutralization epitopes on retroviruses. In this study, the neutralizing capacity of lectins and anti-carbohydrate monoclonal antibodies was found to block infection by cell-free pseudotypes in CD4-negative cells. We suggest that although viral cofactors might expand the tropism of HIV in vivo, HIV and HTLV-I seem to induce common carbohydrate neutralization epitopes.
authors.affiliation: Department of Infectious Diseases, University of Copenhagen, Hvidovre Hospital, Denmark.
authors.forename: A M
authors.initials: AM
authors.lastname: Sørensen
authors.forename: C
authors.initials: C
authors.lastname: Nielsen
authors.forename: M
authors.initials: M
authors.lastname: Arendrup
authors.forename: H
authors.initials: H
authors.lastname: Clausen
authors.forename: J O
authors.initials: JO
authors.lastname: Nielsen
authors.forename: E
authors.initials: E
authors.lastname: Osinaga
authors.forename: A
authors.initials: A
authors.lastname: Roseto
authors.forename: J E
authors.initials: JE
authors.lastname: Hansen
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D002241:Carbohydrates / Q000276:immunology*; D002460:Cell Line; D000939:Epitopes / Q000032:analysis / Q000276:immunology; D015726:Giant Cells / Q000276:immunology; D006678:HIV / Q000276:immunology* / Q000502:physiology; D015488:HIV Antigens / Q000032:analysis / Q000276:immunology*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D037102:Lectins / Q000276:immunology; D009500:Neutralization Tests; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000276:immunology / Q000502:physiology; D015531:Radioimmunoprecipitation Assay
chemical_list: D000911:Antibodies, Monoclonal; D002241:Carbohydrates; D000939:Epitopes; D015488:HIV Antigens; D007106:Immune Sera; D037102:Lectins